Daebongls.Co.Ltd (078140) - Total Assets

Latest as of September 2025: ₩255.44 Billion KRW ≈ $173.11 Million USD

Based on the latest financial reports, Daebongls.Co.Ltd (078140) holds total assets worth ₩255.44 Billion KRW (≈ $173.11 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See 078140 total equity for net asset value and shareholders' equity analysis.

Daebongls.Co.Ltd - Total Assets Trend (2011–2024)

This chart illustrates how Daebongls.Co.Ltd's total assets have evolved over time, based on quarterly financial data.

Daebongls.Co.Ltd - Asset Composition Analysis

Current Asset Composition (December 2024)

Daebongls.Co.Ltd's total assets of ₩255.44 Billion consist of 48.3% current assets and 51.8% non-current assets.

Asset Category Amount (KRW) % of Total Assets
Cash & Equivalents ₩18.10 Billion 0.0%
Accounts Receivable ₩19.11 Billion 8.0%
Inventory ₩16.39 Billion 6.9%
Property, Plant & Equipment ₩81.30 Billion 34.1%
Intangible Assets ₩822.87 Million 0.3%
Goodwill ₩0.00 0.0%

Asset Composition Trend (2011–2024)

This chart illustrates how Daebongls.Co.Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Daebongls.Co.Ltd market cap and net worth.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Daebongls.Co.Ltd's current assets represent 48.3% of total assets in 2024, an increase from 0.0% in 2011.
  • Cash Position: Cash and equivalents constituted 0.0% of total assets in 2024, down from 6.0% in 2011.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2011.
  • Asset Diversification: The largest asset category is property, plant & equipment at 34.1% of total assets.

Daebongls.Co.Ltd Competitors by Total Assets

Key competitors of Daebongls.Co.Ltd based on total assets are shown below.

Company Country Total Assets
JW Shinyak Corporation
KQ:067290
Korea ₩64.75 Billion
Oscotec Inc
KQ:039200
Korea ₩154.14 Billion
Sam Chun Dang Pharm. Co. Ltd
KQ:000250
Korea ₩529.96 Billion
ST Pharm Co.Ltd
KQ:237690
Korea ₩782.57 Billion
Caregen Co.Ltd
KQ:214370
Korea ₩233.98 Billion
NatureCell Co.Ltd
KQ:007390
Korea ₩71.32 Billion
Mezzion Pharma Co.Ltd
KQ:140410
Korea ₩87.88 Billion
Kolon Life Science Inc
KQ:102940
Korea ₩642.14 Billion

Daebongls.Co.Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 5.58 4.77 8.44
Quick Ratio 4.64 4.23 7.35
Cash Ratio 0.00 0.62 0.00
Working Capital ₩82.77 Billion ₩97.60 Billion ₩93.07 Billion

Daebongls.Co.Ltd - Advanced Valuation Insights

This section examines the relationship between Daebongls.Co.Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 0.87
Latest Market Cap to Assets Ratio 0.00
Asset Growth Rate (YoY) 22.5%
Total Assets ₩238.71 Billion
Market Capitalization $78.14 Million USD

Valuation Analysis

Below Book Valuation: The market values Daebongls.Co.Ltd's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.

Rapid Asset Growth: Daebongls.Co.Ltd's assets grew by 22.5% over the past year, indicating significant expansion of the company's resource base.

Annual Total Assets for Daebongls.Co.Ltd (2011–2024)

The table below shows the annual total assets of Daebongls.Co.Ltd from 2011 to 2024.

Year Total Assets Change
2024-12-31 ₩238.71 Billion
≈ $161.77 Million
+22.47%
2023-12-31 ₩194.92 Billion
≈ $132.09 Million
+4.72%
2022-12-31 ₩186.14 Billion
≈ $126.14 Million
+14.03%
2021-12-31 ₩163.24 Billion
≈ $110.62 Million
+8.97%
2020-12-31 ₩149.79 Billion
≈ $101.51 Million
+46.68%
2019-12-31 ₩102.13 Billion
≈ $69.21 Million
+17.47%
2018-12-31 ₩86.93 Billion
≈ $58.91 Million
+8.06%
2017-12-31 ₩80.45 Billion
≈ $54.52 Million
+6.66%
2016-12-31 ₩75.43 Billion
≈ $51.12 Million
+15.21%
2015-12-31 ₩65.47 Billion
≈ $44.37 Million
+15.58%
2014-12-31 ₩56.65 Billion
≈ $38.39 Million
+11.00%
2013-12-31 ₩51.03 Billion
≈ $34.58 Million
+9.64%
2012-12-31 ₩46.55 Billion
≈ $31.54 Million
+6.18%
2011-12-31 ₩43.84 Billion
≈ $29.71 Million
--

About Daebongls.Co.Ltd

KQ:078140 Korea Pharmaceuticals
Market Cap
$78.14 Million
₩115.30 Billion KRW
Market Cap Rank
#20160 Global
#1162 in Korea
Share Price
₩10400.00
Change (1 day)
-2.16%
52-Week Range
₩9560.00 - ₩14890.00
All Time High
₩23750.00
About

Daebongls.Co.,Ltd. engages in the research, development, and production of cosmetics, pharmaceutical raw materials, food and feed products in South Korea and internationally. The company's Cosmetic Ingredients division offers special cosmetic ingredients comprising fresh green tea, black ginseng water, jeju hatban extract, wormwood extract, jeju camellia oil, jeju dang oil extract, jeju basalt po… Read more